CLINICAL_TRIALS
trial_result
· 2025-02-11
Clinical Trial Update: A Study of Midostaurin Efficacy and Safety in Newly Diagnosed Patients With FLT3-mutated AML [Phase 2]
Summary
A Phase 2 trial assessing the efficacy and safety of midostaurin in newly diagnosed FLT3-mutated acute myeloid leukemia has completed enrollment and posted resu…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2025-02-11